Drug Trial Radar · NCT03467477
Tau Screening Study in Subjects With Early Symptomatic AD
Last checked: Nov 20, 2026Latest source record: Aug 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
161
Actual
Start
Mar 8, 2018
Primary completion
Nov 15, 2018
Study completion Nov 15, 2018
Sponsor
- Lead sponsor
- Avid RadiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 16, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 60 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This protocol is designed to serve as a pre-screening study for subjects who are potentially eligible for Alzheimer's Disease (AD) therapeutic trials that require tau imaging for inclusion by means of a flortaucipir F18 Positron Emission Tomography (PET) scan.
Conditions
- Alzheimer Disease
Interventions
Flortaucipir F18Drug
370 megabecquerel (MBq) IV single-dose
Brain PET ScanProcedure
positron emission tomography (PET) scan of the brain
Primary outcomes
What the sponsor says the trial is designed to measure.
- Flortaucipir Qualitative Results (Visual Reads)Time frame: baseline scan
- Flortaucipir Quantitative Results (SUVr)Time frame: baseline scan
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Irvine Center for Clinical Research
Irvine, California
Brain Matters Research
Delray Beach, Florida
Neuropsychiatric Research Center of Southwest Florida
Fort Myers, Florida
Renstar Medical Research
Ocala, Florida
BioClinica Research
Orlando, Florida
Progressive Medical Research
Port Orange, Florida
Great Lakes Clinical Trials
Chicago, Illinois
Cotton O'neil Clinical Research Center
Topeka, Kansas
Butler Hospital
Providence, Rhode Island
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.